Phase 4 Lupus trials recruiting now

All Lupus trials, every phase

Other phases for Lupus

Phase 4 Lupus trials

• A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE)
  NCT06411249 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 114 locations
• A Study to Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132
  NCT06875960 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 4 locations
• Assessing Residual Inflammation and Macrophage Presence in Lupus Nephritis After 3 Months of Intensified Treatment With Prednisolone, Mycofenolate Mofetil and Voclosporin as Compared to Mycofenolate Mofetil and Prednisolone
  NCT07760480 · Phase: Phase 4 · Ages: 16 Years to 70 Years · Sex: All (male and female) · 1 location
• Carotid Ultrasound-Based Strategy for Primary Prevention of Cardiovascular Events in Inflammatory Rheumatic Disease (PREVENER)
  NCT07611747 · Phase: Phase 4 · Ages: 50 Years and older · Sex: All (male and female) · 34 locations
• Childhood-onset Lupus Nephritis Initial Glucocorticoid-dose Harmonization Trial (LIGHT Trial)
  NCT07719140 · Phase: Phase 4 · Ages: 6 Years to 18 Years · Sex: All (male and female) · 8 locations
• Dapagliflozin in Active Lupus Nephritis
  NCT07323524 · Phase: Phase 4 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 2 locations
• Effects of Telitacicept vs Cyclophosphamide on Lupus Related Interstitial Lung Disease
  NCT07077486 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis
  NCT05207358 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis
  NCT07611214 · Phase: Phase 4 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 27 locations
• Prospective Registry Investigating Maternal, Infant, and Lactation Outcomes in Anifrolumab Users
  NCT06594068 · Phase: Phase 4 · Ages: 18 Years to 130 Years · Sex: Female · 1 location
• Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial
  NCT07225387 · Phase: Phase 4 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 7 locations
• Safety and Immunogenicity of the Live Attenuated Tetravalent Butantan-Dengue Vaccine in Autoimmune Rheumatic Diseases
  NCT07087912 · Phase: Phase 4 · Ages: 12 Years to 59 Years · Sex: All (male and female) · 4 locations
• Safety of the Herpes Zoster Subunit Vaccine in Lupus
  NCT05559671 · Phase: Phase 4 · Ages: 18 Years to 90 Years · Sex: All (male and female) · 2 locations
• The Efficacy of Empagliflozin on Kidney Functions in Lupus Nephritis Population
  NCT07700940 · Phase: Phase 4 · Ages: 18 Years to 65 Years · Sex: All (male and female) · 1 location
• Trial of Belimumab in Early Lupus
  NCT03543839 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Common questions

What does Phase 4 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.